0001209191-23-049516.txt : 20230914 0001209191-23-049516.hdr.sgml : 20230914 20230914194101 ACCESSION NUMBER: 0001209191-23-049516 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230912 FILED AS OF DATE: 20230914 DATE AS OF CHANGE: 20230914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YEAMAN KEVIN J CENTRAL INDEX KEY: 0001200469 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32431 FILM NUMBER: 231256280 MAIL ADDRESS: STREET 1: C/O DOLBY LABORATORIES, INC. STREET 2: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dolby Laboratories, Inc. CENTRAL INDEX KEY: 0001308547 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 900199783 STATE OF INCORPORATION: DE FISCAL YEAR END: 0927 BUSINESS ADDRESS: STREET 1: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 415 558 0200 MAIL ADDRESS: STREET 1: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-09-12 0 0001308547 Dolby Laboratories, Inc. DLB 0001200469 YEAMAN KEVIN J C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET SAN FRANCISCO CA 94103 1 1 0 0 President and CEO 0 Class A Common Stock 2023-09-12 4 M 0 18060 42.98 A 69939 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Class A Common Stock 2023-09-12 4 S 0 16711 82.5645 D 53228 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Class A Common Stock 2023-09-12 4 S 0 1349 83.3096 D 51879 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Class A Common Stock 119557 D Employee Stock Option (Right to Buy) 42.98 2023-09-12 4 M 0 18060 0.00 D 2024-12-15 Class A Common Stock 18060 72486 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 The shares were sold in multiple transactions at prices ranging from $82.10 to $83.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold in multiple transactions at prices ranging from $83.11 to $83.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Shares held following the reported transactions include 119,557 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2022 which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption. /s/ Daniel Rodriguez, as Attorney-in-Fact for Kevin Yeaman 2023-09-14